To evaluate the safety and efficacy of neuroendoscopic assisted surgery for clot evacuation in patients with basal ganglion hemorrhage in high altitude regions.

A retrospective analysis was performed on 32 cases of cerebral hemorrhage in the basal ganglia treated by neuroendoscopic surgery at our department from August 2020 to August 2022, and 32 cases who underwent traditional craniotomy in the same period were randomly selected as controls. The clinical data and surgical efficacy of the two groups were compared.

There were no significant differences in gender, age, time of onset before surgery, history of hypertension, history of diabetes, amount of hematoma, or preoperative GCS score between the two groups (P>0.05). The operative time, intraoperative blood loss, ICU stay time, and total hospital stay in the neuroendoscopy group were lower than those of the traditional craniotomy group (P>0.05). There were no significant differences in postoperative hematoma clearance rate, perioperative complications (pneumonia, venous thrombosis of lower extremity, stress ulcer), modified Rankin score (mRS) at discharge, or mRS 3 months later between the two groups (P>0.05).

Treatment of basal ganglion hemorrhage by neuroendoscopic surgery is minimally invasive, safe, and effective.